Prospective cohort study of C-reactive protein as a predictor of clinical events in adults with congenital heart disease: results of the Boston adult congenital heart disease biobank

European Heart Journal - Tập 39 Số 34 - Trang 3253-3261 - 2018
Alexander R. Opotowsky1,2, Anne Marie Valente1,2, Laith Alshawabkeh3, Susan Cheng2,4, Allison Bradley1, Eric B. Rimm5,6,7, Michael J. Landzberg1,2
1Department of Cardiology, Boston Children's Hospital, Harvard Medical School, 300 Longwood Avenue, Boston, MA, USA
2Division of Cardiovascular Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, 75 Francis Street, Boston, MA, USA
3Division of Cardiovascular Medicine, Department of Medicine, University of California San Diego, 200 West Arbor Drive, San Diego, CA, USA
4Framingham Heart Study, 73 Mount Wayte Avenue, Suite 2, Framingham, MA, USA
5Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, 75 Francis Street, Boston, MA, USA
6Department of Epidemiology, Harvard T.H. Chan School of Public Health, 677 Huntington Avenue, Boston, MA, USA
7Department of Nutrition, Harvard T.H. Chan School of Public Health, 677 Huntington Avenue Boston, MA, USA

Tóm tắt

Từ khóa


Tài liệu tham khảo

Gilboa, 2016, Congenital heart defects in the United States: estimating the magnitude of the affected population in 2010, Circulation, 134, 101, 10.1161/CIRCULATIONAHA.115.019307

O’Leary, 2013, The changing demographics of congenital heart disease hospitalizations in the United States, 1998 through 2010, JAMA, 309, 984, 10.1001/jama.2013.564

Ridker, 2017, Antiinflammatory therapy with canakinumab for atherosclerotic disease, N Engl J Med, 377, 1119, 10.1056/NEJMoa1707914

Koenig, 1999, C-Reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study, 1984 to 1992, Circulation, 99, 237, 10.1161/01.CIR.99.2.237

Ridker, 2000, C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women, N Engl J Med, 342, 836, 10.1056/NEJM200003233421202

Kistorp, 2005, N-terminal pro-brain natriuretic peptide, C-reactive protein, and urinary albumin levels as predictors of mortality and cardiovascular events in older adults, JAMA, 293, 1609, 10.1001/jama.293.13.1609

Kaptoge, 2010, The Emerging Risk Factors Collaboration. C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis, Lancet, 375, 132, 10.1016/S0140-6736(09)61717-7

Ridker, 2016, A test in context: high-sensitivity C-reactive protein, J Am Coll Cardiol, 67, 712, 10.1016/j.jacc.2015.11.037

Genest, 2009, 2009 Canadian Cardiovascular Society/Canadian guidelines for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease in the adult—2009 recommendations, Can J Cardiol, 25, 567, 10.1016/S0828-282X(09)70715-9

Stone, 2014, 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines, J Am Coll Cardiol, 63, 2889, 10.1016/j.jacc.2013.11.002

Piepoli, 2016, 2016 European Guidelines on cardiovascular disease prevention in clinical practice: the Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts) developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR), Eur Heart J, 37, 2315, 10.1093/eurheartj/ehw106

Catapano, 2016, 2016 ESC/EAS guidelines for the management of dyslipidaemias, Eur Heart J, 37, 2999, 10.1093/eurheartj/ehw272

Opotowsky, 2016, Design and implementation of a prospective adult congenital heart disease Biobank, World J Pediatr Congenit Heart Surg, 7, 734, 10.1177/2150135116672648

Warnes, 2001, Task force 1: the changing profile of congenital heart disease in adult life, J Am Coll Cardiol, 37, 1170, 10.1016/S0735-1097(01)01272-4

Levey, 2009, A new equation to estimate glomerular filtration rate, Ann Intern Med, 150, 604, 10.7326/0003-4819-150-9-200905050-00006

Ridker, 2006, C-Reactive Protein and Cardiovascular Disease, 1st ed

Eindhoven, 2015, High-sensitive troponin-T in adult congenital heart disease, Int J Cardiol, 184, 405, 10.1016/j.ijcard.2015.02.027

Scognamiglio, 2014, C-reactive protein in adults with pulmonary arterial hypertension associated with congenital heart disease and its prognostic value, Heart, 100, 1335, 10.1136/heartjnl-2014-305494

Miyamoto, 2016, Prognostic value of multiple biomarkers for cardiovascular mortality in adult congenital heart disease: comparisons of single-/two-ventricle physiology, and systemic morphologically right/left ventricles, Heart Vessels, 31, 1834, 10.1007/s00380-016-0807-0

Lakoski, 2006, Gender and C-reactive protein: data from the Multiethnic Study of Atherosclerosis (MESA) cohort, Am Heart J, 152, 593, 10.1016/j.ahj.2006.02.015

Pai, 2004, Inflammatory markers and the risk of coronary heart disease in men and women, N Engl J Med, 351, 2599, 10.1056/NEJMoa040967

Ridker, 2009, Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial, Lancet, 373, 1175, 10.1016/S0140-6736(09)60447-5

Baggen, 2017, Prognostic value of N-terminal pro-B-type natriuretic peptide, Troponin-T, and growth-differentiation factor 15 in adult congenital heart disease, Circulation, 135, 264, 10.1161/CIRCULATIONAHA.116.023255

Opotowsky, 2016, Galectin-3 is elevated and associated with adverse outcomes in patients with single ventricle Fontan circulation, J Am Heart Assoc, 5, e002706., 10.1161/JAHA.115.002706

Baggen, 2018, Prognostic value of galectin-3 in adults with congenital heart disease, Heart, 104, 394, 10.1136/heartjnl-2017-312070

Ky, 2012, Multiple biomarkers for risk prediction in chronic heart failure, Circ Heart Fail, 5, 183, 10.1161/CIRCHEARTFAILURE.111.965020

Thông tin
Thông tin xuất bản

European Heart Journal

Tập 39 Số 34

3253-3261

Thông tin tác giả